Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 339

1.

Examining the Support Peer Supporters Provide Using Structural Equation Modeling: Nondirective and Directive Support in Diabetes Management.

Kowitt SD, Ayala GX, Cherrington AL, Horton LA, Safford MM, Soto S, Tang TS, Fisher EB.

Ann Behav Med. 2017 Apr 17. doi: 10.1007/s12160-017-9904-2. [Epub ahead of print]

PMID:
28417438
2.

Risk of Acute Coronary Heart Disease After Sepsis Hospitalization in the REasons for Geographic and Racial Differences in Stroke Cohort.

Wang HE, Moore JX, Donnelly JP, Levitan EB, Safford MM.

Clin Infect Dis. 2017 Mar 23. doi: 10.1093/cid/cix248. [Epub ahead of print]

PMID:
28369197
3.

Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status.

Colantonio LD, Richman JS, Carson AP, Lloyd-Jones DM, Howard G, Deng L, Howard VJ, Safford MM, Muntner P, Goff DC Jr.

J Am Heart Assoc. 2017 Mar 17;6(3). pii: e005676. doi: 10.1161/JAHA.117.005676.

4.

Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising.

Curtis JR, Chen L, Higginbotham P, Nowell WB, Gal-Levy R, Willig J, Safford M, Coe J, O'Hara K, Sa'adon R.

Arthritis Res Ther. 2017 Mar 7;19(1):48. doi: 10.1186/s13075-017-1251-y.

5.

Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) Classification: a retrospective population-based cohort study.

Donnelly JP, Safford MM, Shapiro NI, Baddley JW, Wang HE.

Lancet Infect Dis. 2017 Mar 3. pii: S1473-3099(17)30117-2. doi: 10.1016/S1473-3099(17)30117-2. [Epub ahead of print]

PMID:
28268067
6.

Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.

Mefford M, Safford MM, Muntner P, Durant RW, Brown TM, Levitan EB.

Int J Cardiol. 2017 Jun 1;236:462-465. doi: 10.1016/j.ijcard.2017.02.105. Epub 2017 Feb 22.

PMID:
28259549
7.

Association of Diabetes and Insulin Therapy With Risk of Hospitalization for Infection and 28-Day Mortality Risk.

Donnelly JP, Nair S, Griffin R, Baddley JW, Safford MM, Wang HE, Shapiro NI.

Clin Infect Dis. 2017 Feb 15;64(4):435-442. doi: 10.1093/cid/ciw738. No abstract available.

PMID:
28174913
8.

Cardiovascular Health and Healthcare Utilization and Expenditures Among Medicare Beneficiaries: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.

Aaron KJ, Colantonio LD, Deng L, Judd SE, Locher JL, Safford MM, Cushman M, Kilgore ML, Becker DJ, Muntner P.

J Am Heart Assoc. 2017 Feb 1;6(2). pii: e005106. doi: 10.1161/JAHA.116.005106.

9.

Seeing the Person, Not the Illness: Promoting Diabetes Medication Adherence Through Patient-Centered Collaboration.

Schwartz DD, Stewart SD, Aikens JE, Bussell JK, Osborn CY, Safford MM.

Clin Diabetes. 2017 Jan;35(1):35-42. doi: 10.2337/cd16-0007.

PMID:
28144044
10.

Heat Maps of Hypertension, Diabetes Mellitus, and Smoking in the Continental United States.

Loop MS, Howard G, de Los Campos G, Al-Hamdan MZ, Safford MM, Levitan EB, McClure LA.

Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). pii: e003350. doi: 10.1161/CIRCOUTCOMES.116.003350.

PMID:
28073852
11.

Does Identification of Previously Undiagnosed Conditions Change Care-Seeking Behavior?

Myerson RM, Colantonio LD, Safford MM, Huang ES.

Health Serv Res. 2017 Jan 10. doi: 10.1111/1475-6773.12644. [Epub ahead of print]

PMID:
28070913
12.

Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims.

Burwen DR, Wu C, Cirillo D, Rossouw JE, Margolis KL, Limacher M, Wallace R, Allison M, Eaton CB, Safford M, Freiberg M.

Thromb Res. 2017 Feb;150:78-85. doi: 10.1016/j.thromres.2016.11.015. Epub 2016 Nov 15.

PMID:
28063368
13.

Cholesterol levels and long-term rates of community-acquired sepsis.

Guirgis FW, Donnelly JP, Dodani S, Howard G, Safford MM, Levitan EB, Wang HE.

Crit Care. 2016 Dec 23;20(1):408. doi: 10.1186/s13054-016-1579-8.

14.

D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Zakai NA, McClure LA, Judd SE, Kissela B, Howard G, Safford M, Cushman M.

Thromb Haemost. 2017 Feb 28;117(3):618-624. doi: 10.1160/TH16-07-0519. Epub 2016 Dec 22.

PMID:
28004063
15.

Diabetes and Insulin Therapy are associated with Increased Risk of Hospitalization for Infection but not Mortality: A Longitudinal Cohort Study.

Donnelly JP, Nair S, Griffin R, Baddley JW, Safford MM, Wang HE, Shapiro NI.

Clin Infect Dis. 2016 Dec 7. pii: ciw738. [Epub ahead of print]

PMID:
27927868
16.

Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).

Mondesir FL, Brown TM, Muntner P, Durant RW, Carson AP, Safford MM, Levitan EB.

Am Heart J. 2016 Nov;181:43-51. doi: 10.1016/j.ahj.2016.08.002. Epub 2016 Aug 12.

PMID:
27823692
17.

Dietary flavonoid intake and incident coronary heart disease: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Goetz ME, Judd SE, Safford MM, Hartman TJ, McClellan WM, Vaccarino V.

Am J Clin Nutr. 2016 Nov;104(5):1236-1244. Epub 2016 Sep 21.

PMID:
27655439
18.

Healthcare Fragmentation and the Frequency of Radiology and Other Diagnostic Tests: A Cross-Sectional Study.

Kern LM, Seirup JK, Casalino LP, Safford MM.

J Gen Intern Med. 2017 Feb;32(2):175-181. doi: 10.1007/s11606-016-3883-z. Epub 2016 Oct 27.

PMID:
27796694
19.

Effects of Concurrent Depressive Symptoms and Perceived Stress on Cardiovascular Risk in Low- and High-Income Participants: Findings From the Reasons for Geographical and Racial Differences in Stroke (REGARDS) Study.

Sumner JA, Khodneva Y, Muntner P, Redmond N, Lewis MW, Davidson KW, Edmondson D, Richman J, Safford MM.

J Am Heart Assoc. 2016 Oct 10;5(10). pii: e003930.

20.

Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.

Look AHEAD Research Group., Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0. Epub 2016 Aug 30.

PMID:
27595918

Supplemental Content

Loading ...
Support Center